On February 19, 2025, Orchestra Biomed Holdings Inc. approved new compensation policies for executive officers, including a cash bonus plan tied to performance goals and a revised vesting schedule for restricted stock units (RSUs). The cash bonuses can reach up to 100% of target amounts based on achieving specific goals related to company projects and financial objectives.